Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NJFY0807311M |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Fast awakening from anesthesia is one of the major characteristics of remifentanil-associated anesthetic induction and maintenance, whereas corresponding pain during awakening influences patient's rehabilitation strongly. In addition, such early postoperative pain results in significant stress responses, which displays as further release of stress hormones such as cortisol and β-endorphin as well. How to prevent such acute pain resulting from remifentanil's fast metabolism endows clinical significance. This study is designed to compare the analgesic efficacy of fentanyl, sufentanil and butorphanol delivered after gynecological laparoscopic surgeries that underwent remifentanil induction and maintenance, and investigate corresponding influence on the levels of blood cortisol and β-endorphin.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Active Comparator | Fentanyl delivered for controlling awaking pain |
|
| 2 | Active Comparator | Sufentanil delivered for controlling awaking pain |
|
| 3 | Active Comparator | Butorphanol delivered for controlling awaking pain |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fentanyl citrate | Drug | Fentanyl 0.5 μg/kg delivered intravenously immediate at the end of remifentanil pump finished |
|
| Measure | Description | Time Frame |
|---|---|---|
| VAS ratings of pain | 0 min after awake from anesthesia; 5,10,15,20 and 30min after awake from anesthesia |
| Measure | Description | Time Frame |
|---|---|---|
| Hemodynamics of patients | 30min before operation; every 10min during operation; 5,10,15,20,30 and 60min after operation | |
| Sedative ratings with VAS system | 0,5,10,15,25,45 and 60min after awake from anesthesia |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| XiaoFeng Shen, MD | Nanjing Medical University | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Nanjing Maternal and Child Health Care Hospital | Nanjing | Jiangsu | 210004 | China |
Not provided
| ID | Term |
|---|---|
| D010149 | Pain, Postoperative |
| ID | Term |
|---|---|
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010146 | Pain |
Not provided
Not provided
| ID | Term |
|---|---|
| D005283 | Fentanyl |
| D017409 | Sufentanil |
| D002077 | Butorphanol |
| ID | Term |
|---|---|
| D010880 | Piperidines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D009019 | Morphinans |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Sufentanil citrate | Drug | Sufentanil 0.05 μg/kg delivered intravenously immediate at the end of remifentanil pump finished |
|
|
| Butorphanol tartrate | Drug | Butorphanol 0.01 mg/kg delivered intravenously immediate at the end of remifentanil pump finished |
|
|
| Overall VAS satisfaction ratings | 1 h after operation |
| Blood cortisol and β-endorphin levels | 0, 10min before the end of surgeries, 10min, 1h and 6h after operation |
| Side effects | 1 h after operation |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D053610 |
| Opiate Alkaloids |
| D000470 | Alkaloids |
| D006572 | Heterocyclic Compounds, Bridged-Ring |
| D006576 | Heterocyclic Compounds, 4 or More Rings |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D010616 | Phenanthrenes |
| D011084 | Polycyclic Aromatic Hydrocarbons |
| D011083 | Polycyclic Compounds |